Chemical Compound

UNII-VDXVABRQTV

CAS Registry Number 207395-85-5
Back to search Request a Quote
UNII-VDXVABRQTV chemical structure
Primary Record

UNII-VDXVABRQTV

In stock
9,435 g
Purity
99.2 %
CAS
207395-85-5

Compound Identifiers & Properties

CAS
207395-85-5
PubChem CID
9855284
SMILES
C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](C6CCCCC6)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H]7C[C@H](CN7C(=O)CCCC(=O)O)O)O
Canonical SMILES
COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)CCCC(=O)O)C2CCCCC2)[C@H](O)[C@H](C)O1

Names & Synonyms

  • UNII-VDXVABRQTV
  • VDXVABRQTV
  • RefChem:151750
  • orb1987162
  • CHEMBL3093499
  • SCHEMBL29412206
  • SCHEMBL29412207
  • L-377202
  • 207395-85-5
  • Doxorubicin Prodrug L-377,202
  • L 377202
  • AKOS040745976
  • CID9855284
  • CID 9855284
  • L-377202-000H
  • L-377,202
  • J1.660.881E
  • 5-[(2S,4R)-2-[[(2S)-1-[[(2S)-1-[[(1S)-2-[[(2S)-5-amino-1-[[(2S)-3-hydroxy-1-[[(2S)-1-[[(2S,3S,4S,6R)-3-hydroxy-2-methyl-6-[[(1S,3S)-3,5,12-trihydroxy-3-(2-hydroxyacetyl)-10-methoxy-6,11-dioxo-2,4-dihydro-1H-tetracen-1-yl]oxy]oxan-4-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-1-cyclohexyl-2-oxoethyl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]carbamoyl]-4-hydroxypyrrolidin-1-yl]-5-oxopentanoic acid
  • 5,12-Naphthacenedione, 10-((3-(((4R)-1-(4-carboxy-1-oxobutyl)-4-hydroxy-L-prolyl-L-alanyl-L-seryl-(2S)-2-cyclohexylglycyl-L-glutaminyl-L-seryl-L-leucyl)amino)-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S,10S)-
  • (8S)-10alpha-[3-[[1-(4-Carboxybutyryl)-t4Hyp-Ala-Ser-[(S)-2-cyclohexyl-Gly-]Gln-Ser-Leu-]amino]-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyloxy]-7,8,9,10-tetrahydro-6,8alpha,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione
  • (8S,10S)-10-[[3-[[1-(4-Carboxybutyryl)-t4Hyp-Ala-Ser-[(S)-2-cyclohexyl-Gly-]Gln-Ser-Leu-]amino]-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl]oxy]-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione
  • 5,12-NAPHTHACENEDIONE, 10-((3-(((4R)-1-(4-CARBOXY-1-OXOBUTYL)-4-HYDROXY-L-PROLYL-L-ALANYL-L-SERYL-(2S)-2-CYCLOHEXYLGLYCYL-L-GLUTAMINYL-L-SERYL-L-LEUCYL)AMINO)-2,3,6-TRIDEOXY-.ALPHA.-L-LYXO-HEXOPYRANOSYL)OXY)-7,8,9,10-TETRAHYDRO-6,8,11-TRIHYDROXY-8-(2-HYDROXYACETYL)-1-METHOXY-, (8S,10S)-
  • 5-((2S,4R)-2-(((1S)-2-(((1S)-2-(((1S)-2-(((1S)-4-AMINO-1-(((1S)-1-(HYDROXYMETHYL)-2-(((1S)-1-(((2S,3S,4S,6R)-3-HYDROXY-2-METHYL-6-(((1S,3S)-3,5,12-TRIHYDROXY-3-(2-HYDROXYACETYL)-10-METHOXY-6,11-DIOXO-2,4-DIHYDRO-1H-TETRACEN-1-YL)OXY)TETRAHYDROPYRAN-4-YL)CARBAMOYL)-3-METHYL-BUTYL)AMINO)-2-OXO-ETHYL)CARBAMOYL)-4-OXO-BUTYL)AMINO)-1-CYCLOHEXYL-2-OXO-ETHYL)AMINO)-1-(HYDROXYMETHYL)-2-OXO-ETHYL)AMINO)-1-METHYL-2-OXO-ETHYL)CARBAMOYL)-4-HYDROXY-PYRROLIDIN-1-YL)-5-OXO-PENTANOIC ACID
  • 5-[(2S,4R)-2-{[(1S)-1-{[(1S)-1-{[(S)-{[(1S)-3-carbamoyl-1-{[(1S)-2-hydroxy-1-{[(1S)-1-{[(2S,3S,4S,6R)-3-hydroxy-2-methyl-6-{[(1S,3S)-3,5,12-trihydroxy-3-(2-hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl]oxy}oxan-4-yl]carbamoyl}-3-methylbutyl]carbamoyl}ethyl]carbamoyl}propyl]carbamoyl}(cyclohexyl)methyl]carbamoyl}-2-hydroxyethyl]carbamoyl}ethyl]carbamoyl}-4-hydroxypyrrolidin-1-yl]-5-oxopentanoic acid